Abstract
Rationale
Nitric oxide (NO) is implicated in the acute locomotor activating effects of some addictive drugs such as amphetamine and cocaine, but has not been investigated in the case of caffeine.
Objectives
We investigated the effects of a nitric oxide synthase (NOS) inhibitor Nω-Nitro-l-arginine methyl ester (l-NAME) and a combination of l-arginine, a NO precursor, and l-NAME on caffeine induced locomotor activity in Swiss Webster mice.
Methods
Locomotor activity was recorded for 30 min immediately following caffeine (0.25–128 mg/kg) or saline administration. In a further study, l-NAME (15 and 30 mg/kg) was administered to another group of mice 30 min before caffeine (1 and 16 mg/kg) injections. Finally, l-arginine (1000 mg/kg), a nitric oxide precursor, was administered 20 min before the l-NAME (15 and 30 mg/kg) treatments and locomotor activities were again recorded immediately after caffeine (1 and 16 mg/kg) injections.
Results
Caffeine (0.5–16 mg/kg) significantly increased locomotor activity, while l-NAME (30 mg/kg) blocked caffeine (1 and 16 mg/kg)-induced locomotor activity. The low dose of l-NAME blocked only caffeine (1 mg/kg)-induced locomotor activity. l-Arginine reversed the inhibitory effects of l-NAME on caffeine-induced locomotor activity. l-NAME and l-arginine had no effect on the locomotor activity of the mice when given by themselves.
Conclusions
The results suggest that caffeine-induced locomotor activity might be modulated by NO in mice.
Similar content being viewed by others
References
Antoniou K, Kafetzopoulos E, Papadopoulou-Daifoti Z, Hyphantis T, Marselos M (1998) d-Amphetamine, cocaine and caffeine: a comparative study of acute effects on locomotor activity and behavioural patterns in rats. Neurosci Biobehav Rev 23:189–196
Bhardwaj A, Northington FJ, Koehler RC, Stiefel T, Hanley DF, Traystman RJ (1995) Adenosine modulates N-methyl-d-aspartate-stimulated hippocampal nitric oxide production in vivo. Stroke 26:1627–1633
Bruhwyeler J, Chleide E, Liégeois JF, Carreer F (1993) Nitric oxide: a new messenger in the brain. Neurosci Biobehav Rev 17:373–384
Bredt DS, Snyder SH (1992) Nitric oxide, a novel neuronal messenger. Neuron 8:3–11
Calapai G, Squadrito F, Altavilla D, Zingarelli B, Compo GM, Cilia M, Caputi AP (1992) Evidence that nitric oxide modulates drinking behavior. Neuropharmacology 31:761–64
Çelik T, Zagli Ü, Kayir H, Uzbay IT (1999) Nitric oxide synthase inhibition blocks amphetamine-induced locomotor activity in mice. Drug Alcohol Depend 56:109–113
Daly JW, Fredholm BB (1998) Caffeine—an atypical drug of dependence. Drug Alcohol Depend 51:199–206
Dunwiddie TV, Masino SA (2001) The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci 24:31–55
El Yacoubi M, Ledent C, Mënard JF, Parmentier M, Costentin J, Vaugeois JM (2000) The stimulant effects of caffeine on locomotor behavior in mice are mediated through its blockade of adenosine A2A receptors. Br J Pharmacol 129:1465–1473
Evans SM, Griffiths RR (1992) Caffeine tolerance and choice in humans. Psychopharmacology 108:51–59
Evans SM, Griffiths RR (1999) Caffeine withdrawal: a parametric analysis of caffeine dosing conditions. J Pharmacol Exp Ther 289:285–294
Fuxe K, Ferre S, Zoli M, Agnati LF (1998) Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia. Brain Res Brain Res Rev 26:258–273
Garrett BE, Holtzman SG (1994) D1 and D2 dopamine receptor antagonists block caffeine-induced stimulation of locomotor activity in rats. Pharmacol Biochem Behav 47:89–94
Itzhak Y (1997) Modulation of cocaine- and metamphetamine-induced behavioral sensitization by inhibition of brain nitric oxide synthase. J Pharmacol Exp Ther 282:521–527
Kaplan GB, Greenblatt DJ, Kent MA, Cotreau-Bibbo MM (1993) Caffeine treatment and withdrawal in mice: relationships between dosage, concentrations, locomotor activity and A1 adenosine receptor binding. J Pharmacol Exp Ther 226:1563–1572
Kaputlu I, Uzbay IT (1997) l-NAME inhibits pentylenetetrazole and strychinine-induced seizures in mice. Brain Res 753:98–101
Kuzmin A, Johansson B, Fredholm BB, Ögren SO (2000) Genetic evidence that cocaine and caffeine stimulate locomotion in mice via different mechanisms. Life Sci 66:PL 113–118
Leza J-C, Lizasoain I, Cuéllar B, Moro MA, Lorenzo P (1996) Correlation between brain nitric oxide synthase activity and opiate withdrawal. Naunyn-Schmeideberg’s Arch Pharmacol 353:349–354
Marston HM, Finlayson K, Maemato T, Olverman HJ, Akahane A, Sharkey J, Butcher SP (1998) Pharmacological characterization of a simple behavioral response mediated selectively by central adenosine A1 receptors, using in vivo and in vitro techniques. J Pharmacol Exp Ther 285:1023–1030
Moore PK, Oluyomi AU, Babbedge RC, Wallace P, Hart SL (1991) L-NG-nitro arginine methyl ester exhibits antinociceptive activity in the mouse. Br J Pharmacol 102:198–202
Morley JE, Flood JF (1991) Evidence that nitric oxide modulates food intake in mice. Life Sci 49:707–11
Mumford GK, Holtzmann GK (1991) Qualitative differences in the discrimination stimulus effects of low and high doses of caffeine in the rat. J Pharmacol Exp Ther 258:857–865
Nikodijević O, Jacobson KA, Daly JW (1993) Locomotor activity in mice during chronic treatment with caffeine and withdrawal. Pharmacol Biochem Behav 44:199–216
Ohno M, Watanabe S (1995) Nitric oxide synthase inhibitors block behavioral sensitization to metamphetamine in mice. Eur J Pharmacol 275:39–44
Przegalinski E, Filip M (1997) Nitric oxide (NO) pathway and locomotor hyperactivity towards dopaminomimetics in rats. Pol J Pharmacol 49:291–298
Pudiak CM, Bozarth MA (1993) l-NAME and MK-801 attenuate sensitization to locomotor-stimulating effect of cocaine. Life Sci 53:1517–1524
Robinson TE, Berridge KC (2001) Incentive-sensitization and addiction. Addiction 96:103–114
Snyder SH (1992) Nitric oxide: first in a new class of neurotransmitters. Science 257:494–496
Snyder SH, Katims JJ, Annau Z, Bruns RF, Daly JW (1981) Adenosine receptors and behavioral actions of methylenexanthines. Proc Natl Acad Sci 78:3260–3264
Svenningson P, Nomikos GC, Fredholm BB (1995) Biphasic changes in locomotor behavior and in expression of mRNA for NGFI-A and NGFI-B in rat striatum following acute caffeine administration. J Neurosci 15:7612–7624
Uzbay IT, Kayir H (2003) Bromocriptine and quinpirole but not 7-OH-DPAT and SKF 38393 potentiate the inhibitory effect of l-NAME on ethanol-induced locomotor activity in mice. Naunyn-Schmeideberg’s Arch Pharmacol 367:414–421
Uzbay IT, Oglesby MW (2001) Nitric oxide and substance dependence. Neurosci Biobehav Rev 25:43–52
Uzbay IT, Erden BF, Tapanyiğit EE, Kayaalp SO (1997) Nitric oxide synthase inhibition attenuates signs of ethanol withdrawal in rats. Life Sci 61:2197–2209
Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94:469–497
Yamada K, Noda Y, Nakayama S, Komori Y, Sugihara H, Hasegawa T, Nabeshima T (1995) Role of nitric oxide in learning and memory and in monoamine metabolism in the rat brain. Br J Pharmacol 115:852–858
Yildiz F, Ulak G, Erden BF, Gacar N (2000) Anxiolytic-like effects of 7-nitroindazole in the rat plus-maze test. Pharmacol Biochem Behav 65:199–202
Acknowledgements
This study was supported by State Planning Institution and Ministry of Defence of Turkish Government (grant no: DPT-MSB-3, 99K120150).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kayir, H., Uzbay, I.T. Evidence for the role of nitric oxide in caffeine-induced locomotor activity in mice. Psychopharmacology 172, 11–15 (2004). https://doi.org/10.1007/s00213-003-1625-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-003-1625-5